KURA - Kura Oncology GAAP EPS of -$0.53 beats by $0.03
- Kura Oncology press release ( NASDAQ: KURA ): Q3 GAAP EPS of -$0.53 beats by $0.03 .
- Net loss for the third quarter of 2022 was $35.5 million, compared to a net loss of $33.4 million for the third quarter of 2021.
- Shares -1.4% PM.
For further details see:
Kura Oncology GAAP EPS of -$0.53 beats by $0.03